MCM

M28 Capital Management Portfolio holdings

AUM $58.6M
This Quarter Return
-37.21%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$109M
AUM Growth
+$109M
Cap. Flow
+$24.8M
Cap. Flow %
22.79%
Top 10 Hldgs %
95.32%
Holding
14
New
2
Increased
7
Reduced
1
Closed
1

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$5.24M
2
TGTX icon
TG Therapeutics
TGTX
$4.95M
3
WVE icon
Wave Life Sciences
WVE
$4.17M
4
VERV
Verve Therapeutics
VERV
$4.07M
5
CRIS icon
Curis
CRIS
$3.89M

Top Sells

1
NKTR icon
Nektar Therapeutics
NKTR
$7.57M
2
ATRA icon
Atara Biotherapeutics
ATRA
$627K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IVVD icon
1
Invivyd
IVVD
$204M
$29.2M 26.83% 6,398,250 +733,029 +13% +$3.34M
WVE icon
2
Wave Life Sciences
WVE
$1.53B
$11.7M 10.76% 5,850,000 +2,084,412 +55% +$4.17M
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$354M
$11.4M 10.44% 715,880 +220,600 +45% +$3.5M
STOK icon
4
Stoke Therapeutics
STOK
$1.08B
$11.1M 10.2% 527,150 – –
CRIS icon
5
Curis
CRIS
$20.9M
$10.1M 9.29% 4,243,293 +1,634,442 +63% +$3.89M
TGTX icon
6
TG Therapeutics
TGTX
$4.65B
$9.97M 9.16% 1,047,900 +520,900 +99% +$4.95M
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.82M 6.27% 82,900 +63,700 +332% +$5.24M
BBIO icon
8
BridgeBio Pharma
BBIO
$9.89B
$4.73M 4.35% 466,200 – –
LPTX icon
9
Leap Therapeutics
LPTX
$12M
$4.66M 4.29% 2,664,400 +1,664,400 +166% +$2.91M
VERV
10
DELISTED
Verve Therapeutics
VERV
$4.07M 3.74% +178,500 New +$4.07M
ATRA icon
11
Atara Biotherapeutics
ATRA
$84.6M
$3.62M 3.33% 389,353 -67,512 -15% -$627K
PRQR icon
12
ProQR Therapeutics
PRQR
$237M
$907K 0.83% +1,001,800 New +$907K
NEXI
13
DELISTED
NexImmune, Inc. Common Stock
NEXI
$562K 0.52% 133,442 – –
NKTR icon
14
Nektar Therapeutics
NKTR
$568M
– – -560,600 Closed -$7.57M